Last close As at 05/08/2026
GBP0.03
— 0.00 (0.00%)
Market capitalisation
GBP5m
Research: TMT
We believe that factors are finally aligning to support adoption of Nanoco’s quantum dots in the 250m+ unit per year TV and computer display markets. With a large addressable market and an operationally geared model, it does not take aggressive assumptions for earnings to scale and the rating to look very inexpensive. We believe a substantial re-rating upwards would be justified as support for our estimates builds.
Written by
Nanoco Group |
Quantum leap |
Initiation of coverage |
Tech hardware & equipment |
11 May 2017 |
Share price performance
Business description
Next events
Analyst
Nanoco group is a research client of Edison Investment Research Limited |
|||||||||||||||||||||||||||||||||||||||||||||||
We believe that factors are finally aligning to support adoption of Nanoco’s quantum dots in the 250m+ unit per year TV and computer display markets. With a large addressable market and an operationally geared model, it does not take aggressive assumptions for earnings to scale and the rating to look very inexpensive. We believe a substantial re-rating upwards would be justified as support for our estimates builds.
Year |
Revenue (£m) |
PBT* |
EPS* |
DPS |
EV/sales |
P/E |
07/16 |
0.5 |
(12.3) |
(5.2) |
0.0 |
131.5 |
N/A |
07/17e |
1.6 |
(10.2) |
(4.3) |
0.0 |
38.4 |
N/A |
07/18e |
16.3 |
0.8 |
0.3 |
0.0 |
3.8 |
96.4 |
07/19e |
32.2 |
12.4 |
4.9 |
0.0 |
1.9 |
6.6 |
Note: *PBT and EPS are normalised and diluted, excluding intangible amortisation, exceptional items and share-based payments.
Quantum dot uptake cycle in display to hit its stride
Quantum dots (QDs) significantly enhance the colour range of LCD displays, enabling a picture quality competitive with the rival OLED technology with better energy efficiency. Implementing the technology requires little disruption to the established LCD TV supply chain and therefore the cost is substantially lower than OLED. Market analysts’ adoption forecasts vary but at the mid-point, QD TV shipments are forecast to grow from c 5m in 2017 to nearly 50m by 2020, which we estimate equates to a market opportunity for QD materials of $550m by 2020.
Nanoco looks well placed to take market share
Nanoco has pioneered the development and has core IP for scale manufacture of cadmium-free quantum dots, which are forecast to dominate QD TV volumes. This has enabled the company to secure two licensees, Dow and Merck, both well entrenched in the display supply chain. The Dow relationship has been beset by delays, but it has built significant capacity and appears to be moving closer to securing production orders. Merck is on track with a commercialisation schedule and holds a significant share (est 60%) of the liquid crystal for liquid crystal displays (LCD) market. Significant efficiency gains made to Nanoco’s production process have opened up the opportunity to supply materials for volume manufacture, where the company expects to receive c 10x the gross profit per TV that it receives for licensing. Nanoco’s first customer for volume materials, Wah Hong, has demonstrated devices from three OEMs – Hisense, TCL and TPV Philips –holding a combined 15% of the TV market and discussions are ongoing with six more. We estimate that capturing 1% of the announced OEMs’ volumes would generate £8-9m revenue for Nanoco.
Valuation: Heroic assumptions not needed
Once all partners are up and running (likely in 2019), it does not take aggressive assumptions for Nanoco’s earnings to scale and the rating to look very inexpensive. As further support for our base case materialises, we would expect the shares to progressively rate upwards towards a mid-high teens forward P/E rating, suggesting a share price of 70p plus within 24 months.
Investment case
Focus on penetrating the 250m+ unit pa display market
Nanoco is the leading commercial supplier of cadmium-free quantum dots (CFQD), nanoscale particles that emit light when energised, with the colour of the light emitted being determined by the size of the particle. Quantum dots have potential in a number of different applications and Nanoco has development initiatives in medical imaging, lighting, solar cell and displays. The core focus, however, is on the display market, where quantum dots are being used to enhance the picture quality in higher-end televisions and computer displays, initially through using a film coated in red and green QDs (circa 1g per m² of film or 55-inch television) to convert the blue-weighted LED back light into pure white light. Future evolutions are under development to use QDs to enhance the LCD filter and eventually to use QD LEDs to create the picture and light source. Market analysts’ forecasts for QD adoption in display vary, but at the mid-point, QD TV shipments are forecast to grow from c 5m in 2017 to nearly 50m by 2020, which we estimate equates to a market opportunity for QD materials of $550m by 2020.
Hybrid model, expanding coverage of the display supply chain
Nanoco Group operates a hybrid IP licensing and material supply model. Its two licensees, Dow Chemical and Merck, are both well-established suppliers into the display marketplace and will pay Nanoco a low double-digit percentage royalty of value of their product sold. Enabled by significant gains in production efficiency at its Runcorn manufacturing facility, Nanoco is now able to produce and sell materials for volume manufacture as well as for development purposes. The company has established a materials supply partnership with Wah Hong, a leading Taiwanese supplier of films to primarily Chinese/Taiwanese manufacturers. Nanoco has demonstrated televisions from three brands, Hisense, TCL and TPV Philips, using Wah Hong/Nanoco film and discussions are ongoing with a further six. We do not have visibility on pricing, but we expect Nanoco to receive circa $38/m2 (1m2 is roughly the area of a 60” TV) at a 60% gross margin initially. The contribution per m2 from licensees is considerably lower; we estimate $1.9/m2 initially, but licensees are likely better placed to secure the very high-volume orders from tier one brands.
On the cusp of volume sales, earnings should scale quickly
Following a long gestation period, Nanoco is on the cusp of commercialisation. Market analysts are forecasting strong uptake of QD TVs and cadmium free is expected to dominate volumes. Dow is now moving closer to volume orders and is, we believe, still well placed to secure a position as second source supplier to Samsung. Merck could start contributing in FY18. We estimate that it will be FY19 before all of these partners contribute a full year of ramped volume production, but with costs recently trimmed and expected to remain relatively fixed after that, margins and profits should scale quickly once overheads are offset.
In our base case scenario, Nanoco expands product market share to 4% and licensees attain 23% market share by 2019 in which case EBITDA margins expand to 42%. In Exhibit 1 we show three alternative scenarios for FY19: 1) in which Nanoco’s licensees succeed in taking significant (50%) share of the QD TV market; 2) in which Nanoco gains robust market share (8%) with its own material; and 3) where combined market share remains below 25%. In all bar the third scenario, Nanoco generates strong profits and margins. The company will consume some working capital as volumes ramp, but with high gross margins and modest capex requirements, the model should be strongly cash generative once it does so. The company had net cash of £8.3m on the balance at the end of H117, which we forecast dropping to £3.4m by end July 2018. Cash burn depends heavily on the rate and timing of the ramp in volume shipments, meaning that one cannot rule out the possibility of dilution to strengthen the balance sheet.
Exhibit 1: Scenarios
Year end 30 July |
Base case |
1) Bull royalty |
2) Bull product |
3) Bear |
||||
2016 |
2017e |
2018e |
2019e |
2019e |
2019e |
2019e |
||
Royalty volumes (m m2 or 60" TV equiv) |
0.0 |
0.0 |
2.6 |
7.5 |
23.4 |
4.6 |
4.6 |
|
Product volumes (m m2 or 60" TV equiv) |
0.0 |
0.0 |
0.4 |
0.9 |
0.9 |
2.6 |
0.7 |
|
Total revenues (£m) |
0.5 |
1.6 |
16.3 |
32.2 |
44.0 |
57.2 |
23.6 |
|
EBITDA (£m) |
(11.2) |
(9.1) |
1.7 |
13.5 |
25.2 |
26.9 |
4.4 |
|
Margin |
loss |
loss |
loss |
42% |
57% |
47% |
19% |
|
EPS* (p) |
(5.2) |
(4.3) |
0.3 |
4.9 |
9.45 |
10.58 |
1.27 |
|
EV/EBITDA (x) |
loss |
loss |
loss |
4.4 |
2.4 |
2.2 |
13.5 |
|
P/E (x) |
N/A |
N/A |
96.4 |
6.6 |
3.3 |
3.0 |
24.5 |
|
Source: Edison Investment Research. Note:* EPS is shown as normalised and diluted.
Valuation
We believe that delivery to any of the above scenarios other than the bear case would justify significant share price appreciation. While direct peers do not exist, IP based manufacturing and licensing businesses typically trade at high forward multiples – rarely below the mid-teens. Applying an 18x P/E multiple to our base case forecasts, then discounting back one year by 20% a year, would suggest a 70p fair value on a 12-18 month timescale.
We believe that the key catalysts for the company to grow into this rating, or to price in a more optimistic scenario are: 1) visibility of revenues and expansion of OEM relationships through Wah Hong; 2) progress with licensees in securing OEM customers and moving to production; and 3) adding other customers for material supply.
Looking longer term, successful commercialisation of future generations of QD-based displays – using QDs to enhance the LCD filter and eventually using QD-based LEDs to create both the picture and light source – should drive a sustained multi-phase growth cycle for quantum dots. If Nanoco can maintain a market leadership position in these developments, then higher ratings would be justifiable. Universal Display Corp (OLED US), which is perhaps the closest peer in terms of business model, but focused on OLED rather than QD and a decade ahead of Nanoco in terms of commercialisation, is trading at 64x current year earnings, dropping to 28x on a two-year forward basis.
Sensitivities
Nanoco’s financial performance and investment case will be determined by four key factors: the rate of uptake of quantum dots in the display market, Nanoco’s market share, pricing and the revenue mix between royalties and material sales. We have used scenarios to best illustrate a range of potential outcomes, but with estimates made at each level, there is clear scope for the company to perform outside of this range. Near-term visibility is particularly limited with financial performance particularly exposed to the timing of product launches as well as the above factors.
Other sensitivities include intellectual property – quantum dots are a heavily IP protected arena. IP disputes have already taken place and could factor in the future. With over 550 issued and pending patents, this could be an upside or downside driver for Nanoco. In Europe the ban on cadmium’s use in lighting and display is subject to an exception that lasts until July 2017. A consultation is underway on whether to extend this by a further two years, which would strengthen the position of cadmium-based suppliers. However, with Samsung prominently highlighting the cadmium-free nature of its quantum dot televisions, OEMs using cadmium are exposing their brands to negative publicity. In the longer term other factors will come in to play, including Nanoco’s ability to secure a strong market position in second-generation (QD Filter) and third-generation (QDLED) QD televisions and its commercial progress in other applications, such as medical imaging, lighting and solar.
Set for a quantum leap?
Introduction to quantum dots
Quantum dots (QDs) are very small semiconductor particles – with a diameter of 10-100 atoms – that emit different colours of light when energized, typically by light or electricity with a high degree of efficiency. The wavelength (and hence frequency) of the light emitted is dictated by the size of the particle – the smaller the dot the shorter the wavelength. This makes it possible to produce very pure light (ie with a very narrow band of wavelengths) by energising a solution or material containing quantum dots that are all of a very similar size. Very precisely tuned light can be produced by combining quantum dots of two or three different sizes.
|
Exhibit 2: Layers of a quantum dot |
Exhibit 3: Different colours emitted depending on size |
|
|
|
Source: Edison Investment Research, IHS |
Source: Nanoco Group |
|
Exhibit 2: Layers of a quantum dot |
|
|
Source: Edison Investment Research, IHS |
|
Exhibit 3: Different colours emitted depending on size |
|
|
Source: Nanoco Group |
These properties mean that Quantum dots can be applied to a number of different applications, including:
■
TV and displays, where they are being used to improve colour gamut (range) and efficiency of displays.
■
Lighting, where quantum dots can be used to tune light for specialist applications (eg horticultural lighting, signage and dermatology) and potentially general lighting in the longer term.
■
Medical imaging, where quantum dots can offer advantages over traditional fluorescent dyes for applications such as cancer detection.
Outside of quantum dots, Nanoco also has a development in thin film solar, using copper indium gallium selenide (CIGS) technology to broaden the range of wavelengths converted to electricity and thus improve the efficiency of thin film solar cells.
This report focuses on the opportunity within TV and display, as it is sizeable and by far the most developed, with Nanoco-based product set to move into volume production in the near future. Each of the other verticals has the potential to generate significant revenues in their own right, but the pathway to commercialisation is not yet clear, and will remain secondary to the overall investment case until clearer commercial milestones are passed.
Better picture, efficiency with little supply chain disruption
Quantum dot technology is an attractive option for the display industry, because it improves the colour range, brightness and efficiency of LCD televisions, while using a similar display architecture, minimising disruption and investment into a well-established supply chain.
We show a simplified breakdown of a quantum dot television in Exhibit 4. An LCD television is very similar, with a backlight unit (BLU) providing the source of light, while the picture is generated by the LCD panel, with thousands of pixels that block or let through a light, which then passes through a red, green and blue pixelated filter to add colour.
The colour range of traditional LCD displays is limited by the LED backlight, which does not provide adequate emission of the red and green portions of the light spectrum. While this issue is partially addressed by using coloured films that block out blue and other unwanted colours, the process is not perfect and energy is wasted in blocking out larger ranges of colour.
In a quantum dot LCD (QDLCD) television, the filter is replaced by a film incorporating quantum dots. These dots are ‘excited’ by light emitted from blue LEDs, transforming some of it into very pure green and red light, while the blue is passed through. As a result, the LCD panel receives a richer white light made up of three narrow bands of red, green and blue, which in turn expands the range or gamut of colour that the display can reproduce.
The amount of quantum dot material used per television is very small – circa 1 gram for a 55” screen (circa 0.83m2). These are contained in a proprietary resin, which enables the quantum dots to be applied while preventing them from degrading through contact with air.
|
Exhibit 4: Simplified breakdown of a QDLCD display |
|
|
Source: Edison Investment Research |
Expanding coverage of the supply chain
Over the past 12 months, Nanoco has significantly expanded and diversified its coverage of the display supply chain and we expect this process to continue. We show a simplified schematic of the quantum dot display supply chain in Exhibit 5. While Nanoco has developed direct relationships with the television OEMs and panel manufacturers, the company’s direct customers are earlier on in the supply chain – either chemical suppliers or film suppliers, which then supply panel manufacturers, which supply OEMs.
In Dow and Merck we believe that Nanoco has relationships with major chemical companies that can potentially cover a significant proportion of the supply chain. The supply landscape of film and panel manufacturers is fragmented and relatively parochial, with Taiwanese/Chinese, Korean and Japanese suppliers mainly serving their domestic OEMs. Consequently, we believe that Nanoco will likely seek to establish relationships with film manufacturers exposed to the Japanese markets to complement its relationship with Wah Hong.
The company is currently in discussions with nine OEMs in total regarding 14 projects. We expect both a proportion of these to convert into commercial shipment volumes and for the number of projects to expand.
|
Exhibit 5: The QDLCD supply chain |
|
|
Source: Edison Investment Research |
Dow Chemical – delayed, but still in the game
Nanoco entered into an exclusive partnership/licensing agreement for the display market with Dow Chemical in 2013, but progress was not as rapid as expected, possibly slowed by the merger with Dupont. In 2015 Samsung opted to use Hansol (using Samsung developed IP) as primary supplier of CFQD material for its first generation of QD televisions. In March 2016 the companies negotiated a move to a non-exclusive partnership, giving Nanoco the freedom to pursue alternative routes to the display market in exchange for a lower royalty rate (not disclosed) and ceding rights to earn-out income from Dow. While progress has been slow, Dow remains active in the quantum dot market through its Trevista brand and has invested significantly in building a facility in Cheonan, South Korea, with capacity to produce CFQDs for millions of televisions a year and with room for expansion. With one line ready for production, we understand that Dow has capacity to produce QDs to supply millions of square metres of display screen and could therefore generate greater than $2.5m per annum of royalty for Nanoco before investing in new equipment. Nanoco reports that Dow is making good progress in sampling product, and we believe it is in pole position to be the second source of CFQD material to Samsung and to other OEMs.
Merck – significant penetration of the display market
Following the move to non-exclusive with Dow, Nanoco announced a licensing partnership with Merck in August 2016. In Merck the company has a partner with a significant presence and vested interest in the LCD display market. Merck is the leading supplier of liquid crystals into the LCD display market with an estimated market share of c 60%, meaning that it is strongly in Merck’s interest to stave off any potential threat from OLED (see page 9). Merck is on track with its commercialisation programme and is already producing samples in its Darmstadt plant and has plans to build a volume manufacturing facility that could potentially become operational before year end 2018, with Nanoco supplying the material in the interim.
Wah Hong – first OEMs announced, capacity investment brought forward
Nanoco’s first customer for its CFQD product (dots and resin) is Wah Hong, one of the world's largest manufacturers of optical films and sheets for displays. Wah Hong is based in Taiwan and has a number of facilities across the region and supplies to a range of Asian panel and TV manufacturers. Wah Hong already has facilities to produce CFQD film with little modification and therefore can move to volume production in a short timescale. The company has optimised its equipment for producing films of up to 60” for CFQD film production and has recently moved forward planned investment in a second line, capable of supplying films for screens of up to 100”. This line is expected to be operational before the end of June 2017.
At the Consumer Electronics Show (CES) in January, three manufacturers, Hisense, TCL and TPV Philips, displayed large-screen, ultra-high definition, wide colour gamut quantum dot televisions using Nanoco’s CFQD Fine Color Film, manufactured by Wah Hong. According to Statistica, these manufacturers held a combined 15% of the TV market in 2015, equating to over 30m units shipped. We estimate that Nanoco would generate revenue of £8-9m if it were to capture 1% of these OEMs’ shipments. Discussions are ongoing with a further six OEMs.
Korea manufacturers lead the market, China the rising force
Samsung and LG currently hold a commanding position of the top two spots in TV market share. As previously discussed, we believe that Nanoco through Dow remains in pole position to be second source supplier in the near term, although Merck also has a strong relationship with the market number one. Given LG’s commitment to OLED, we believe that it is unlikely to offer a significant opportunity for Nanoco in the near term. Together the two Korean giants hold around a third of the market in terms of TVs shipped and this figure is greater for higher-end, larger TV sets.
|
Exhibit 6: TV OEM market share 2015 |
|
|
Source: Statistica |
Nevertheless, there is still a significant proportion of the market to go for outside of these two vendors. In particular, it is important to note the rise of the Chinese OEMs and panel manufacturers. Chinese OEMs have taken significant market share from the Japanese brands, and also hold well over 40% market share and now some of the once prominent Western/Japanese brands – such as Philips (by TPV) and Sharp (Hisense).
On the panel building side, Chinese LCD flat panel display makers have been aggressively expanding capacity for a number of years. A June 2016 article by IHS estimated that China would have 28 flat panel display fabs by 2018 with Chinese share of LCD production capacity growing to 29% (vs estimated 22% in 2016) overtaking Taiwan and closing in on Korea (estimated 40% in 2016). The report also states that Chinese players are focusing on larger screens – 50” and above. We believe that this capacity build is likely to support adoption of QDLCD televisions, in that falling LCD costs will widen the price differential between QDLCD and OLED. We believe that the improved image and marketing benefits of QDLCD together with the easy adaption of supply chains should make QDLCD an attractive option for OEMs.
We believe that the relative fragmentation of the supply chain in China should make it more supportive of Nanoco’s material supply business compared to Korea, where we believe that licensees will hold sway. Given the substantially stronger revenue and gross margin Nanoco receives per device, successful penetration of the Chinese supply chain could be a very significant value driver for Nanoco.
Financials
Business model
All of Nanoco’s revenues to date have been generated from development related streams: licences, milestone payments and QD shipments for development purposes. The company will generate more of these, but the timing is difficult to predict and they are not particularly material to the investment case.
For volume shipments, the company operates a hybrid IP licensing and material manufacture/supply model.
Partner royalties: Success hinges on high volumes through tier one relationships
As with any royalty model, success depends on generating significant volumes of sales across a broad spectrum of end customers. In Dow and Merck we believe that Nanoco has two partners capable of achieving this. Nanoco will receive a low double-digit percentage royalty on QD material sales through its licensing partners, which will drop directly through to gross and operating profit. In our base case we estimate that royalty per m2 will initially be $2.20 but eroding by 12% each year. As the royalty is set as a percentage of the total value of product sold, the royalty per m2 could be markedly higher should these partners manufacture QD embedded film rather than QD material.
Material supply: Much higher-value, lower-volume
Nanoco’s Runcorn site was originally built to manufacture development volumes of QD material. However, recent process improvements have increased its capacity more than tenfold, opening up the possibility to supply material directly to film manufacturers, with Wah Hong being the first. The economics for supplying a given square metreage of QD material are considerably stronger than for the royalty equivalent. Nanoco will receive the full value of the material at an estimated gross margin of 60% rather than a double-digit percentage royalty. While the company’s large licensee partners are better placed to capture the highest volume devices with tier one OEMS, given the strong economics, there is still good business to be had supplying material for shorter runs of lower tier brands, especially as pricing will generally be higher for these lower-volume devices.
Manufacturing quantum dots is not expected to be a particularly capital intensive process. The company currently has enough capacity to produce QDs for 350k m2 screen coverage or c $14m (£11m) at our estimated initial pricing of $38/m2. This is consistent with IHS’s estimated cost of $57.8 for the QD film for a 55” television (area 0.83m2) assuming that QD material accounts for c 55% of this value. Management estimates that it can also expand capacity at Runcorn by nearly fourfold to deliver enough CFQDs to supply 2m m2 of quantum dots (ie the amount of quantum dots required to cover a given area of display film) with a mere £2m of capex. We forecast a low double-digit rate of price erosion, similar to our royalty forecasts.
Highly operationally geared model
Opex expected to remain relatively flat
The company has recently instigated a cost-trimming process, which we expect to reduce cash operating expenses (excluding depreciation, amortisation, share-based payments) by c £1m to £10.5m. We estimate R&D expenditure at c £5.5m, offset by government grants of c £300k, central costs of £6.7m, with c £1.2m of depreciation spread across the two.
The EBITDA break-even level will depend on the royalty/product sales mix, but once this is reached, with high gross margins, focused R&D and an indirect sales model, growth should drop strongly through to profit. With a strong product uptake cycle and a high IP model, margins could expand to very high levels. In our base case (see Exhibit 14), EBITDA margins expand to 35% by 2019, whereas in a more positive scenario where Nanoco’s licensees take significant (50%) market share, EBITDA margins expand to 52% in the same timeframe.
Determining a ‘target’ long-term margin profile for the business is very difficult. In reality, we believe that the company is likely to increase investment into the business should margins expand to very high levels to support development in fields such as QDLED and other markets, with medical imaging probably holding the most potential. The utopian vision would be for the company to evolve into a high-margin business with diversified exposure across a number of different verticals, although we often see margins peak in the initial product uptake cycle followed by a period of compression as the first cycle wanes and others take time to develop.
Cash flow and balance sheet
The company had £8.3m net cash and equivalents at end January (plus a £1.9m tax credit to be received in H2), consuming £6.2m over the course of H1. In our base case forecast, we have net cash dipping to £3.4m at year end 2018. We believe that the company has options to further reduce costs or factor receivables to help bridge a short-term gap, but clearly one cannot rule out some interim report, whereby essentially no already contracted revenue is received but no action to further reduce costs is taken, indicates that cash resources would run out in the first quarter of calendar year 2018.
While there will be some working capital build and (relatively modest) capex in the growth phase, the business should generate healthy cash flows as the company moves into profit. Royalty revenues will initially be recognised in the quarter of shipment, but paid quarterly in arrears. This means that the receivables balance will look high as a percentage of royalty revenues during the growth phase, although there are no associated expenditures related to royalty revenues. Once royalty streams become predictable, the company will accrue monthly and adjust to actual on a quarterly basis. Wah Hong’s payment terms are 45 days in arrears and the company pays its consumable suppliers in 45 days.
We model an incremental £2m of capex above maintenance levels (sub £1m) spread across 2018 and 2019 to support capacity expansion at Runcorn.
The company has accumulated £24m of tax losses and therefore we do not expect any significant tax charge over our forecast period.
The company has 14m options with an average exercise price of 48.9p. We progressively include this in our diluted EPS estimates over the course of FY18 and FY19.
Estimates and scenarios
On the cusp of volume shipments; real shape should start to emerge from 2019
Forecasting revenues (and even more so earnings) is notoriously difficult at this stage of development due to customer concentration and exposure to the timing at which specific manufacturing programmes commence. Overlaying this is a wide range of potential scenarios as to how the QD display market will develop, market share, pricing and the balance of revenues between royalties and material sales. We have therefore adopted a scenario-based approach, based on varying QD uptake, pricing and Nanoco’s market share for both licensees and its own product. Our scenario assumptions for key market, market share and pricing are detailed in Exhibit 14.
Exhibit 14: Scenario assumptions
Market scenarios |
2016e |
2017e |
2018e |
2019e |
2020e |
Nanoco scenarios |
2016e |
2017e |
2018e |
2019e |
2020e |
||||
Nanoco share of QD market |
|||||||||||||||
Total QD TV market (m m2)* |
|
|
|
|
|
Licensee |
|||||||||
Base |
4.03 |
9.19 |
17.45 |
32.61 |
47.14 |
Base |
0% |
0% |
15% |
23% |
27% |
||||
Bull |
4.07 |
9.39 |
21.19 |
46.82 |
70.97 |
Bull |
0% |
5% |
35% |
50% |
50% |
||||
Bear |
4.00 |
9.00 |
13.70 |
18.40 |
23.30 |
Bear |
0% |
0% |
14% |
14% |
14% |
||||
Total QD & resin market value ($m) |
Product |
||||||||||||||
Base |
84 |
169 |
281 |
463 |
589 |
Base |
0% |
0% |
3% |
4% |
5% |
||||
Bull |
85 |
172 |
311 |
549 |
666 |
Bull |
0% |
1% |
4% |
8% |
10% |
||||
Bear |
83 |
165 |
221 |
261 |
291 |
Bear |
0% |
0% |
1% |
2% |
2% |
||||
Revenue per m2 ($) |
|||||||||||||||
Currency US$/£ |
1.43 |
1.28 |
1.28 |
1.28 |
1.28 |
Licensee |
|||||||||
Base |
2.5 |
2.2 |
1.9 |
1.7 |
1.5 |
||||||||||
Bull |
2.5 |
2.4 |
2.1 |
1.9 |
1.6 |
||||||||||
Bear |
2.5 |
2.2 |
1.8 |
1.4 |
1.1 |
||||||||||
Product |
|||||||||||||||
Base |
45.0 |
38.0 |
35.0 |
30.0 |
27.0 |
||||||||||
Bull |
45.0 |
38.0 |
34.6 |
31.5 |
28.6 |
||||||||||
Bear |
45.0 |
34.2 |
29.8 |
24.0 |
21.6 |
||||||||||
Source: Edison Investment Research. Note: *Total QD & resin market assumes average value/m2 drops from $18.3 in FY17 to $12.5 in FY20. Nanoco’s royalty rate is estimated at 12% of this value. Market size does not include other devices, eg computer display etc.
Strong growth and healthy profitability in most scenarios
In our base case, we assume that volume product sales and royalties both start in FY18. Estimated FY18 product revenues to Wah Hong and other customers of £10.0m equate to a c 0.37m m2 screen area, while royalty revenues of £4.0m equate to 2.6m m2. Our forecasts assume that Dow and Merck capture 24% of the addressable market by 2019, and Nanoco reaches 4% market share with its own product in this year.
We detail three alternative scenarios in Exhibit 15 and in all bar the bear case the company generates very strong growth in sales and very healthy margins within the 2019 timeframe (the earliest for a full year contribution from all three partners). It is worth noting that we always couple high-volume (royalty or material) assumptions with our most aggressive price erosion assumptions, as price and volume are inextricably linked.
Exhibit 15: Key scenario P&L outcomes
£m |
2016 |
2017e |
2018e |
2019e |
2020e |
Base (base case all metrics) |
|||||
Royalty volumes (m m2) |
0.00 |
0.00 |
2.64 |
7.51 |
12.81 |
Product volumes (m m2) |
0.01 |
0.02 |
0.37 |
0.85 |
1.19 |
Royalties |
0.0 |
0.0 |
4.0 |
10.0 |
15.0 |
Product |
0.2 |
0.5 |
10.0 |
20.0 |
25.0 |
Other revenues |
0.3 |
1.1 |
2.3 |
2.2 |
0.7 |
Total revenues |
0.5 |
1.6 |
16.3 |
32.2 |
40.7 |
Gross profit |
0.3 |
1.4 |
12.2 |
24.2 |
30.6 |
EBITDA |
(11.2) |
(9.1) |
1.7 |
13.5 |
18.0 |
Margin |
loss |
loss |
11% |
42% |
44% |
High volume licensing (bull case QD uptake, licensee market share, bear case pricing) |
|||||
Royalties |
0.0 |
0.8 |
10.2 |
25.8 |
31.2 |
Product |
0.2 |
0.5 |
8.5 |
16.0 |
20.0 |
Total revenues |
0.5 |
2.4 |
21.0 |
44.0 |
51.9 |
Gross profit |
0.3 |
2.1 |
16.7 |
35.9 |
41.8 |
EBITDA |
(11.2) |
(8.4) |
6.2 |
25.2 |
29.2 |
Margin |
loss |
loss |
29% |
57% |
56% |
Strong product uptake (base case QD uptake & licensee revenues, bull case product market share, bear case product pricing) |
|||||
Royalties |
0.0 |
0.0 |
3.7 |
6.1 |
7.7 |
Product |
0.1 |
2.5 |
16.2 |
48.9 |
79.5 |
Total revenues |
0.5 |
3.6 |
22.2 |
57.2 |
87.9 |
Gross profit |
0.3 |
2.5 |
15.7 |
37.6 |
56.0 |
EBITDA |
(11.2) |
(8.0) |
5.2 |
26.9 |
43.5 |
Margin |
loss |
loss |
23% |
47% |
49% |
Incumbents retain share (base case QD update, bear case market share for licensee and product, base case pricing) |
|||||
Royalties |
0.0 |
0.0 |
3.7 |
6.1 |
7.7 |
Product |
0.0 |
0.2 |
6.8 |
15.3 |
19.9 |
Total revenues |
0.5 |
1.4 |
12.8 |
23.6 |
28.3 |
Gross profit |
0.2 |
1.2 |
9.0 |
15.1 |
17.3 |
EBITDA |
(11.3) |
(9.7) |
(1.8) |
4.3 |
4.7 |
Margin |
loss |
loss |
loss |
18% |
17% |
Source: Edison Investment Research
Valuation
It does not take aggressive assumptions for Nanoco to look inexpensive on a 2019 timescale. We believe that delivery to any of the above scenarios other than the bear case would justify significant share price appreciation. While direct peers do not exist, IP-based manufacturing and licensing businesses typically trade at high forward multiples, rarely below the mid-teens. Applying an 18x P/E multiple to our base case 2019 EPS would indicate an 88p share price, which discounted back by a year at 20% would suggest a 70p fair value is justifiable within a 12-18-month timeframe.
Exhibit 16: Scenarios
Year end 30 July |
Base |
1) Bull royalty |
2) Bull product |
3) Bear |
||||
2016 |
2017e |
2018e |
2019e |
2019e |
2019e |
2019e |
||
Royalty volumes (m m2 or 60" TV equiv) |
0.0 |
0.0 |
2.6 |
7.5 |
23.4 |
4.6 |
4.6 |
|
Product volumes (m m2 or 60" TV equiv) |
0.0 |
0.0 |
0.4 |
0.9 |
0.9 |
2.6 |
0.7 |
|
Total revenues (£m) |
0.5 |
1.6 |
16.3 |
32.2 |
44.0 |
57.2 |
23.6 |
|
EBITDA (£m) |
(11.2) |
(9.1) |
1.7 |
13.5 |
25.2 |
26.9 |
4.4 |
|
Margin |
loss |
loss |
loss |
42% |
57% |
47% |
19% |
|
EPS* (p) |
(5.2) |
(4.3) |
0.3 |
4.9 |
9.45 |
10.58 |
1.27 |
|
EV/EBITDA |
loss |
loss |
loss |
4.9 |
2.6 |
2.5 |
15.0 |
|
P/E |
N/A |
N/A |
93.4 |
6.4 |
3.6 |
3.2 |
26.7 |
|
Source: Edison Investment Research. Note: *EPS shown as normalised and diluted. Priced at 9 May 2017.
Share price performance in the near term will likely be dictated by the milestones the company achieves as it moves towards volume shipments and expands its coverage of the display supply chain. The company has already achieved a number of these since the start of the year, with three OEMs demonstrating televisions using Nanoco’s CFQDs. We highlight others in Exhibit 17.
Exhibit 17: Timeline of possible value drivers
2016 |
2017 |
2018 |
2019 |
2020 |
|
TV evolution |
QDLCD uptake |
QDFilter TV Launch |
QDLED TV Launch |
||
Partner milestones (display) |
Add Merck, Wah Hong |
Add other film partners |
Visibility of QD filter collaborations |
Visibility of QDLED collaborations |
|
OEM relationships |
Hisense, TCL, TPV Philips + potentially others |
Add others through Dow & potentially Merck and other film manufacturer |
|||
Partners start production |
First Wah Hong orders. Dow also possible |
Dow |
Source: Edison Investment Research
Looking to the longer term, successful commercialisation of future generations of QD-based displays – using QDs to enhance the LCD filter and eventually using QD-based LEDs to create both the picture and light source – should drive a sustained, multiphase growth cycle for quantum dots. If Nanoco can maintain a market leadership position in these developments, then long-term growth prospects should justify a higher rating. Universal Display Corp (OLED US), which is perhaps the closest peer in terms of business model, but focused on OLED rather than QD and a decade ahead of Nanoco in terms of commercialisation, is trading at 64x current year earnings, dropping to 28x on a two-year forward basis.
We have not explored the opportunity for Nanoco in fields outside of display as we feel that, as yet, the initiatives are too early to realistically gauge the opportunity. However, we believe that the announcement of partners in fields such as medical imaging or progress in lighting would justify value being ascribed to these initiatives.
Exhibit 18: Financial summary
£m |
2015 |
2016 |
2017e |
2018e |
2019e |
||
Year end 30 July |
IFRS |
IFRS |
IFRS |
IFRS |
IFRS |
||
INCOME STATEMENT |
|||||||
Revenue |
2.0 |
0.5 |
1.6 |
16.3 |
32.2 |
||
Cost of Sales |
(0.3) |
(0.2) |
(0.3) |
(4.1) |
(8.1) |
||
Gross Profit |
1.7 |
0.3 |
1.4 |
12.2 |
24.2 |
||
EBITDA |
(8.1) |
(11.2) |
(9.1) |
1.7 |
13.5 |
||
Normalised operating profit |
(9.5) |
(12.5) |
(10.2) |
0.6 |
12.1 |
||
Amortisation of acquired intangibles |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
||
Exceptionals |
(0.9) |
0.0 |
0.0 |
0.0 |
0.0 |
||
Share-based payments |
(0.6) |
(0.3) |
(0.3) |
(0.3) |
(0.3) |
||
Reported operating profit |
(11.0) |
(12.8) |
(10.5) |
0.4 |
11.8 |
||
Net Interest |
0.1 |
0.2 |
0.1 |
0.2 |
0.3 |
||
Joint ventures & associates (post tax) |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
||
Exceptionals |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
||
Profit Before Tax (norm) |
(9.3) |
(12.3) |
(10.2) |
0.8 |
12.4 |
||
Profit Before Tax (reported) |
(10.9) |
(12.6) |
(10.4) |
0.6 |
12.1 |
||
Reported tax |
1.9 |
2.0 |
0.0 |
0.0 |
0.0 |
||
Profit After Tax (norm) |
(9.3) |
(12.3) |
(10.2) |
0.8 |
12.4 |
||
Profit After Tax (reported) |
(9.0) |
(10.6) |
(10.4) |
0.6 |
12.1 |
||
Minority interests |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
||
Discontinued operations |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
||
Net income (normalised) |
(9.3) |
(12.3) |
(10.2) |
0.8 |
12.4 |
||
Net income (reported) |
(9.0) |
(10.6) |
(10.4) |
0.6 |
12.1 |
||
Basic average number of shares outstanding (m) |
221 |
221 |
237 |
238 |
238 |
||
EPS - basic normalised (p) |
(4.22) |
(5.20) |
(4.27) |
0.34 |
5.19 |
||
EPS - diluted normalised (p) |
(4.22) |
(5.20) |
(4.27) |
0.33 |
4.90 |
||
EPS - basic reported (p) |
(4.05) |
(4.47) |
(4.39) |
0.23 |
5.08 |
||
Dividend (p) |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
||
Revenue growth (%) |
N/M |
(76.6) |
242.9 |
903.1 |
97.7 |
||
Gross Margin (%) |
84.4 |
62.8 |
83.8 |
75.0 |
74.9 |
||
EBITDA Margin (%) |
N/A |
N/A |
N/A |
10.6 |
41.8 |
||
Normalised Operating Margin |
N/A |
N/A |
N/A |
3.9 |
37.5 |
||
BALANCE SHEET |
|||||||
Fixed Assets |
3.9 |
3.7 |
4.0 |
5.2 |
5.8 |
||
Intangible Assets |
1.8 |
2.4 |
2.9 |
3.0 |
3.2 |
||
Tangible Assets |
2.1 |
1.3 |
1.2 |
2.2 |
2.6 |
||
Investments & other |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
||
Current Assets |
27.2 |
18.7 |
8.5 |
13.0 |
27.2 |
||
Stocks |
0.2 |
0.2 |
0.0 |
0.5 |
1.0 |
||
Debtors |
0.9 |
2.0 |
0.1 |
4.2 |
8.2 |
||
Cash & cash equivalents |
24.3 |
14.5 |
6.4 |
6.3 |
16.1 |
||
Other |
1.8 |
2.0 |
2.0 |
2.0 |
2.0 |
||
Current Liabilities |
(2.0) |
(3.0) |
(2.0) |
(4.8) |
(5.3) |
||
Creditors |
(1.9) |
(2.4) |
(1.3) |
(1.8) |
(2.3) |
||
Tax and social security |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
||
Short term borrowings |
(0.1) |
(0.0) |
0.0 |
(3.0) |
(3.0) |
||
Other |
0.0 |
(0.5) |
(0.6) |
0.0 |
0.0 |
||
Long Term Liabilities |
(0.0) |
(0.6) |
0.0 |
0.0 |
0.0 |
||
Long term borrowings |
(0.0) |
0.0 |
0.0 |
0.0 |
0.0 |
||
Other long term liabilities |
0.0 |
(0.6) |
0.0 |
0.0 |
0.0 |
||
Net Assets |
29.1 |
18.8 |
10.6 |
13.4 |
27.8 |
||
Minority interests |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
||
Shareholders' equity |
29.1 |
18.8 |
10.6 |
13.4 |
27.8 |
||
CASH FLOW |
|||||||
Op Cash Flow before WC and tax |
(8.1) |
(11.2) |
(9.1) |
1.7 |
13.5 |
||
Working capital |
0.2 |
0.5 |
0.5 |
(4.7) |
(4.0) |
||
Exceptional & other |
(0.9) |
0.0 |
0.0 |
0.0 |
0.0 |
||
Tax |
1.3 |
1.8 |
2.0 |
2.0 |
2.0 |
||
Net operating cash flow |
(7.6) |
(8.9) |
(6.7) |
(1.0) |
11.4 |
||
Capex |
(0.9) |
(1.1) |
(1.2) |
(2.3) |
(2.0) |
||
Acquisitions/disposals |
0.0 |
0.0 |
(0.3) |
0.0 |
0.0 |
||
Net interest |
0.1 |
0.2 |
0.1 |
0.2 |
0.3 |
||
Equity financing |
21.1 |
0.0 |
0.0 |
0.0 |
0.0 |
||
Dividends |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
||
Other |
(0.6) |
0.0 |
0.0 |
0.0 |
0.0 |
||
Net Cash Flow |
12.2 |
(9.7) |
(8.1) |
(3.1) |
9.7 |
||
Opening net debt/(cash) |
(12.2) |
(24.4) |
(14.5) |
(6.5) |
(3.4) |
||
FX |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
||
Other non-cash movements |
0.0 |
(0.1) |
0.0 |
0.0 |
0.0 |
||
Closing net debt/(cash) |
(24.4) |
(14.5) |
(6.5) |
(3.4) |
(13.1) |
||
Source: Nanoco Group accounts, Edison Investment Research
|
|||||||||||||||||||||||||||||||||||||||||||||||||||
|
|||||||||
|
|||||||||
Research: Healthcare
Despite a strong run over the last 12 months, our increased valuation of $2.7bn suggests the market overlooks HCM’s full R&D potential. Multiple catalysts are on the horizon in 2017/18; notably the China FDA filing for fruquintinib in CRC (full Phase III CRC data [China] at ASCO) and overall survival data from the savolitinib Phase II trial in c-Met-driven PRCC (could support a US NDA submission). Further progress of the early to mid-stage pipeline over time should retain investors focus. Ultimately, HCM’s move to commercialise its innovative pipeline in its domestic market (and longer term in international territories) could provide a major source of uplift.